Acute estradiol and progesterone therapy in hospitalized adults to reduce COVID-19 severity: a randomized control trial
Sign Up to like & getrecommendations! Published in 2024 at "Scientific Reports"
DOI: 10.1038/s41598-024-73263-5
Abstract: COVID-19 outcomes are less severe in women than men suggesting that female sex is protective. The steroids estradiol (E2) and progesterone (P4) promote anti-inflammatory immune responses and their therapeutic use for COVID-19 has been under… read more here.
Keywords: trial; estradiol progesterone; covid severity; progesterone therapy ... See more keywords